Cost-effectiveness of initiating antiretroviral therapy at different points in TB treatment in HIV-TB co-infected ambulatory patients in South Africa

Initiation of antiretroviral therapy (ART) during tuberculosis (TB) treatment improves survival in TB-HIV coinfected patients. In patients with CD4 counts <50 cells per cubic millimeter, there is a substantial clinical and survival benefit of early ART initiation. The purpose of this study was to assess the costs and cost-effectiveness of starting ART at various time points during TB treatment in patients with CD4 counts ≥50 cells per cubic millimeter.

Author(s)
K, Naidoo., Grobler, AC., Deghaye, N., Reddy, T., Gengiah, S., Gray A and Abdool Karim S
Publication date
2015
Published in
Journal of Acquired Immune Deficiency Syndromes
Volume, issue, & pages
15
DOI
10.1097/QAI.0000000000000673

Cost-effectiveness of initiating antiretroviral therapy at different points in TB treatment in HIV-TB co-infected ambulatory patients in South Africa

Related content

Patterns of disclosure and antiretroviral treatment adherence in a South African mining workplace programme and implications for HIV prevention

Optimizing Differentiated HIV Treatment Models in Urban Zimbabwe: Assessing Patient Preferences Using a Discrete Choice Experiment

A Cross-Country Network Analysis of Adolescent Resilience

Is there really a pot of gold at the end of the rainbow? Has the occupational specific dispensation, as a mechanism to attract and retain health workers in South Africa, leveled the playing field?

Combined structural interventions for gender equality and livelihood security: a critical review of the evidence from southern and eastern Africa and implications for young people